Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
INFACARE PHARMACEUTICAL CORP See All Filings	D	2017-06-07 14:50:43 UTC
Amount To Be Raised $11,000,000 Associated Brokers / Dealers N/A CIK Number 0001174264 Filed Document 0001174264-17-000001 Exclusions or Exemptions 506b Accepted Date 2017-06-07 14:50:43 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business PENNSYLVANIA Revenue or Assets Decline to Disclose Type of Security Other
INFACARE PHARMACEUTICAL CORP See All Filings	D	2016-11-04 13:30:32 UTC
Amount To Be Raised $11,000,000 Associated Brokers / Dealers N/A CIK Number 0001174264 Filed Document 0001174264-16-000002 Exclusions or Exemptions 506b Accepted Date 2016-11-04 13:30:32 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business PENNSYLVANIA Revenue or Assets Decline to Disclose Type of Security Other
INFACARE PHARMACEUTICAL CORP See All Filings	D	2015-07-08 00:00:00 UTC
Amount To Be Raised $12,100,000 Associated Brokers / Dealers N/A CIK Number 0001174264 Filed Document 0001174264-15-000001 Exclusions or Exemptions 506b Accepted Date 2015-07-08 00:00:00 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business PENNSYLVANIA Revenue or Assets Decline to Disclose Type of Security Equity
INFACARE PHARMACEUTICAL CORP See All Filings	D	2014-12-09 00:00:00 UTC
Amount To Be Raised $1,300,000 Associated Brokers / Dealers N/A CIK Number 0001174264 Filed Document 0001174264-14-000002 Exclusions or Exemptions 506b Accepted Date 2014-12-09 00:00:00 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business PENNSYLVANIA Revenue or Assets Decline to Disclose Type of Security Equity
INFACARE PHARMACEUTICAL CORP See All Filings	D	2014-10-21 00:00:00 UTC
Amount To Be Raised $750,000 Associated Brokers / Dealers N/A CIK Number 0001174264 Filed Document 0001174264-14-000001 Exclusions or Exemptions 506b Accepted Date 2014-10-21 00:00:00 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business PENNSYLVANIA Revenue or Assets Decline to Disclose Type of Security Equity